(Q34192399)

31 July 2017

1 reference

title

Neuroscience research in AIDS. (English)

1 reference

31 July 2017

1 reference

Rausch DM

1

1 reference

31 July 2017

Stover ES

series ordinal

2

1 reference

31 July 2017

publication date

1 January 2001

1 reference

Progress in Neuro-Psychopharmacology & Biological Psychiatry

31 July 2017

published in

1 reference

31 July 2017

volume

25

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

231-257

1 reference

Neuropsychologic impairment in early HIV infection. A risk factor for work disability.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1--infected patients with and without AIDS dementia complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

HIV disease treatment in the era of HAART.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Variable progression of HIV-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Pain in ambulatory AIDS patients. I: Pain characteristics and medical correlates.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Effect of continuous-infusion zidovudine therapy on neuropsychologic functioning in children with symptomatic human immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Correlation between computed tomographic brain scan abnormalities and neuropsychological function in children with symptomatic human immunodeficiency virus disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Neuropathology of Human Immunodeficiency Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Assessment of AIDS-related cognitive changes: recommendations of the NIMH Workshop on Neuropsychological Assessment Approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Early viral brain invasion in iatrogenic human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Use of simian immunodeficiency viruses for AIDS research

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Changes to AIDS dementia complex in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Rates of spontaneous mutation among RNA viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Pain and depression in HIV illness

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

HIV-protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Simian immunodeficiency virus: a model for neuroAIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Chemokine receptors in HIV-1 infection of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

HIV infection and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Sentries at the gate: chemokines and the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Leukocyte traffic in the central nervous system: the participants and their roles

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Neuropsychological effects of early HIV-1 infection: assessment and methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Drug concentration heterogeneity facilitates the evolution of drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Medical management of HIV disease in children

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Progression to AIDS: the effects of stress, depressive symptoms, and social support

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Epidemiology of HIV/AIDS in children

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Excitatory amino acids as a final common pathway for neurologic disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Neuronal injury associated with HIV-1: approaches to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Cerebrospinal fluid abnormalities in homosexual men with and without neuropsychiatric findings

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

The impact of HIV-related neuropsychological dysfunction on driving behavior. The HNRC Group

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Treatment of depressive symptoms in human immunodeficiency virus-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Selective neuronal vulnerability in HIV encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Changes in pathological findings at autopsy in AIDS cases for the last 15 years

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Potential factors affecting adherence with HIV therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Cognitive and motor impairments associated with SIV infection in rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

The AIDS dementia complex: I. Clinical features

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

The AIDS dementia complex: II. Neuropathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

A 'second life' agenda. Psychiatric research issues raised by protease inhibitor treatments for people with the human immunodeficiency virus or the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Prevalence of axis I disorders in an AIDS cohort: a cross-sectional, controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

The SIV-infected rhesus monkey model for HIV-associated dementia and implications for neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Survival in children with perinatally acquired human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Neuroleptic treatment of HIV-associated psychosis. HNRC group

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Peptide T in the treatment of painful distal neuropathy associated with AIDS: results of a placebo-controlled trial. The Peptide T Neuropathy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Virologic markers of human immunodeficiency virus type 1 in cerebrospinal fluid. The HIV Neurobehavioral Research Center Group

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Increased cerebral blood volume in HIV-positive patients detected by functional MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Neuropsychological performance in HIV-1 immunocompromised patients: a preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Neocortical damage during HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Receptive and expressive language function of children with symptomatic HIV infection and relationship with disease parameters: a longitudinal 24-month follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Unraveling the mechanisms of neurotoxicity in HIV type 1-associated dementia: inhibition of neuronal synaptic transmission by macrophage secretory products

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2800%2900154-8

7 January 2021

10.1016/S0278-5846(00)00154-8

Identifiers

DOI

1 reference

31 July 2017

1 reference